21 May 2009
Cytomegalovirus infection does not accelerate microvasculopathy development in heart transplant recipients
M Zakliczynski, A Krynicka-Mazurek, D Konecka-Mazurek, J Nożyński, S Żegleń, R Przybylski, M ZembalaAnn Transplant 2009; 14(1): 32-32 :: ID: 880313
Abstract
Background: It was confirmed in clinical studies with intravascular ultrasound
that even subclinical cytomegalovirus (CMV) infection may increase intimal
hyperplasia in transplanted heart's coronary arteries, which is observed at the end of the 1st year after the surgery. A potential influence of CMV on development of microvasculopathy is not known. Aim of the study was to compare occurrence of microvasculopathy in endomyocardial biopsies (EMBs) of heart transplant recipients with or without CMV infection.
Material/Methods: We performed a case-control retrospective study involving 58 pts. with CMV infection confirmed with the presence of pp65 antigen (49M/9F, 49±8y/o, ischemic c-pathy in 52%) and matched 58 control without CMV disease. Microvasculopathy was assessed using 4 degree grading system developed by Hiemann et al. in elective EMBs performed 1 month and 12 months after transplantation.
Results: Significant acute rejection was observed in 22 vs. 21% of 1st month's EMBs, and 3 vs. 5% of 12[sup]th[/sup] month's EMBs in CMV(+) and control group, respectively. Maximal microvasculopathy score was 2.05±0.93 vs. 1.88±0.94 in 1st month's EMBs, and 2.29±1.12 vs. 2.28±1.20 in 12[sup]th[/sup] month's EMBs, respectively. Progression of microvasculopathy score between 1st month and 12th month's EMBs was observed in 40 vs. 41% of pts, and regression occurred in 22 vs. 21% of pts, respectively. None of the differences was statistically significant.
Conclusions: Our data does not support the thesis that CMV infection promotes development of microvasculopathy in heart transplant recipients.
Keywords: CMV infections, Heart Transplantation
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
24 Aug 2021 : Review article
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860